BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12794012)

  • 1. The recent past and future of adjuvant therapy for pancreatic cancer.
    Yeo CJ
    Ann Surg Oncol; 2003 Jun; 10(5):488-9. PubMed ID: 12794012
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.
    Twombly R
    J Natl Cancer Inst; 2008 Dec; 100(23):1670-1. PubMed ID: 19033566
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.
    Vikram B
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577724
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.
    Fujita T
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemoradiation in pancreatic carcinoma].
    Claude L; Mornex F
    Cancer Radiother; 2003 Aug; 7(4):254-65. PubMed ID: 12914858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant strategies for pancreatic cancer.
    Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
    Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
    Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
    JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.
    Desai S; Ben-Josef E; Griffith KA; Simeone D; Greenson JK; Francis IR; Hampton J; Colletti L; Chang AE; Lawrence TS; Zalupski MM
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1450-5. PubMed ID: 19409732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
    Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB
    J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
    Abbruzzese JL
    JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
    Lluís F
    Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
    Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG
    Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
    Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
    Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adjuvant therapy in the management of pancreatic cancer.
    Laheru D; Yeo CJ
    Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoradiation protocols offer only incremental gains for pancreatic cancer patients.
    Bankhead C
    J Natl Cancer Inst; 2002 Nov; 94(22):1670-2. PubMed ID: 12441320
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Saif MW
    JOP; 2009 Jul; 10(4):373-7. PubMed ID: 19581737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of early-stage pancreatic cancer.
    Castellanos EH; Cardin DB; Berlin JD
    Oncology (Williston Park); 2011 Feb; 25(2):182-9. PubMed ID: 21456390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.